Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PROSCOPE

Financiado

Cerrado

Point of care instrument for diagnosis and image guided intervention of Colo Rec...

Point of care instrument for diagnosis and image guided intervention of Colo Rectal Cancer Colorectal cancer (CRC) is the second most common cause of cancer death in Europe, yet survival rates rise dramatically when caught early. A contributing factor is that current colonoscopy, i.e., white light video or optical narro... ver más

31/12/2024

TECHNICAL UNIVERSI...

6M€

Presupuesto del proyecto: 6M€

Líder del proyecto

DANMARKS TEKNISKE UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 12 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-12-31

ICT-05-2019: Application driven Photonics compon...

I+D

Cerrada hace 5 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

12 Participantes

TECHNICAL UNIVERSITY OF DENM...

1.11M€ | Lider

OVE

736.38K€ | Participante

Tuebingen Scietific Medical...

46.58K€ | Participante

Q4 PUBLIC RELATIONS

231.88K€ | Participante

Proyectos interesantes

PICCOLO

Medical Technol...

Data Science

4M€ Cerrado

ColoFast

Medical Technol...

Data Science

3M€ Cerrado

Medical Technol...

Data Science

71K€ Cerrado

COMBIOSCOPY

Medical Technol...

Data Science

1M€ Cerrado

SOFT

Medical Technol...

Data Science

71K€ Cerrado

LEAD

Medical Technol...

Data Science

71K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 61 meses Fecha Inicio: 2019-11-05
Fecha Fin: 2024-12-31

Líder del proyecto

DANMARKS TEKNISKE UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 6M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Colorectal cancer (CRC) is the second most common cause of cancer death in Europe, yet survival rates rise dramatically when caught early. A contributing factor is that current colonoscopy, i.e., white light video or optical narrow band imaging, is inadequate for in-vivo detection and characterisation of the various types of (pre-)cancerous lesions found in the colon. Point-of-care, real-time polyp diagnosis and image guided intervention has the potential to save huge healthcare costs by enabling early onset of treatment; thus reduced recurrence rate, by improving interval screening, and by reducing pathology costs incurred during colonoscopy. A complete, reliable optical diagnosis is sensitive to morphological and biochemical changes. Unfortunately, no single optical method provides both. PROSCOPE provides unique combination of label-free, non-ionizing, proven optical imaging modalities that provides higher sensitivity and specificity compared to current colonoscopy thus enabling a step-change in point-of-care management of CRC. PROSCOPE develops and integrates recent advances in optical imaging and optical probe technology into one platform. The concept is validated in clinical settings using existing endoscopes providing minimally invasive optical imaging that fits into current clinical procedures. A leading medical device manufacturer and clinicians are involved at every stage of the development and validation. PROSCOPE is driven by unmet clinical needs in the field of gastroenterological diagnosis with a clear business case: Combination of optical imaging techniques offers the potential to vastly improve early diagnosis of CRC achieving specificity and sensitivity above 90%, reducing the number of excisional biopsies by 50%, and improving interval screening planning, thereby reducing healthcare costs drastically and benefitting patients. The consortium includes five leading academics, including hospital clinics, and four SMEs covering the entire value chain.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores